Differential platelet protein release profiles in community-acquired pneumonia and COVID-19
Platelet release profiles differ strongly between CAP and COVID-19 patients, wherein platelets from COVID-19 patients released more bioactive products, linking with an adverse clinical outcome.
Authors
- Christine C. A. van Linge (ORCID: https://orcid.org/0000-0003-2787-8895)
- W. Joost Wiersinga (ORCID: https://orcid.org/0000-0003-2277-1343)
- A. Klarenbeek
- Tom van der Poll (ORCID: https://orcid.org/0000-0002-9199-5079)
- Erik H.A. Michels (ORCID: https://orcid.org/0000-0001-8145-2444)
- Justin de Brabander (ORCID: https://orcid.org/0000-0002-3596-5086)
- Osoul Chouchane (ORCID: https://orcid.org/0000-0003-1629-8588)
- Valentine Léopold (ORCID: https://orcid.org/0000-0002-2131-5760)
- Cornelis van ′t Veer
Institutions
- Amsterdam UMC Location University of Amsterdam (NL)
- Amsterdam University Medical Centers (NL)
- University of Amsterdam (NL)
Publication Details
- Journal
- ERJ Open Research
- Published
- 2025-02-27
- DOI
- https://doi.org/10.1183/23120541.00863-2024
- Citations
- 2
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 2.79
Funders
- Landsteiner Foundation for Blood Transfusion Research
- Fondation Bettencourt Schueller
- Institut Servier
- H2020 Health